Identification of a new single nucleotide substitution on the hypoxanthine-guanine phosphoribosyltransferase gene (HPRT(Tsou)) from a Taiwanese aboriginal family with severe gout

Journal of Rheumatology

Volumn 26, Issue 8, 1999, Pages 1802-1807

  Chang, Shun Jen ^b   Chang, Jan Gowth ^b   Chen, Chung Jen ^b   Wang, Jyh Chwan ^b   Ou, Tsan Teng ^b   Chang, Kee Lung ^b   Ko, Ying Chin ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NONE

Author keywords

Aborigines; Gout; HPRT; Hyperuricemia

Indexed keywords

AMINO ACID; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; URIC ACID;

ABORIGINE; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GOUT; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING; TAIWAN; URIC ACID BLOOD LEVEL;

EID: 0344549400     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Seegmiller JE, Rosenbloom FM, Kelley WN. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 1967;155:1682-4.
2. Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med 1964;36:561-70.
3. Kelley WN, Rosenbloom FM, Henderson JF, Seegmiller JE. A specific enzyme defect in gout associated with overproduction of uric acid. Proc Natl Acad Sci USA 1967;57:1735-9.
4. Edwards A, Voss H, Rice P, et al. Automated DNA sequencing of the human HPRT locus. Genomics 1990;6:593-608.
5. Pantel PI, Framson PE, Caskey CT, Chinault AC. Use of selective media for distinguishing variant forms of hypoxanthine phosphoribosyltransferase. Clin Chem Acta 1986;154:195-202.
6. Jolly DJ, Okayama H, Berg P, et al. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci USA 1983;80:477-81.
7. Chang FZ, Chang SJ, Wu YY, Wang TN, Ko YC. Body mass index and hyperuricemia differences between aboriginal and non-aboriginal children in Taiwan. Kaohsiung J Med Sci 1995;11:315-21.
8. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, Chen CJ. High prevalence of gout and related risk factors in Taiwan's Aborigines. J Rheumatol 1997;24:1364-9.
9. Chang JG, Chen PH, Chiou SS, Lee LS, Perng LI, Liu TC. Rapid diagnosis of beta-thalassemia mutations in Chinese by naturally and amplified created restriction sites. Blood 1992;80:2092-6.
10. Yale). Adv Exp Med Biol 1989;253A:135-8.
11. Midland). Gene 1988;68:85-91.
12. Flint). Gene 1988;63:331-6.
13. Fujimori S, Tagaya T, Kamatani N, Akaoka I. A germ line mutation within the coding sequence for the putative 5-phosphoribosyl-1-pyrophosphate binding site of hypoxanthine-guanine phosphoribosyltransferase (HPRT) in a Lesch-Nyhan patient: missense mutations within a functionally important region probably cause disease. Hum Genet 1992;90:385-8.
14. Coorparoo: two Lesch-Nyhan patients with reduced amounts of mRNA. Gene 1991;108:299-304.
15. Montreal) by use of T-lymphocyte cultures. Hum Genet 1990;85:111-6.
16. Madrid) in exon 3 of the human hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene. Hum Genet 1993;91:451-4.
17. Lee WJ, Lee HM, Chi CS, Yang MT, Lin HY, Lin WH. Genetic analysis of the HPRT mutation of Lesch-Nyhan syndrome in a Chinese family. Chin Med J (Taipei) 1995;56:359-66.
18. Davidson BL, Tarle SA, Van Antwerp MV, et al. Identification of 17 independent mutations responsible for human hypoxanthine-guanine phosphoribosyl transferase (HPRT) deficiency. Am J Hum Genet 1991;48:951-8.
19. Munich. Am J Hum Genet 1988;42:726-34.
20. Ashville). J Biol Chem 1989;264:520-5.
21. Ann Arbor). Hum Genet 1988;79:39-43.
22. Wilson JM, Tarr GE, Kelley WN. Human hypoxanthine (guanine) phosphoribosyltransferase: an amino acid substitution in a mutant form of the enzyme isolated from a patient with gout. Proc Natl Acad Sci USA 1983;80:870-3.
23. Brisbane). J Inherit Metab Dis 1990;13:692-700.
24. Tohyama J, Nanba E, Ohno K. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line. Hum Genet 1994;93:175-81.
25. Kelley WN, Wortmann RL. Gout and hyperuricemia. Textbook of rheumatology. Philadelphia: WB Saunders; 1997:1330-1.
26. Becker MA, Losman MJ, Itkin P, Simkin PA. Gout with superactive phosphoribosyl pyrophosphate synthetase due to increased enzyme catalytic rate. J Lab Clin Med 1982;99:495-511.
27. Becker MA, Kim M. Regulation of purine synthesis de novo in human fibroblasts by purine nucleotides and phosphoribosylpyrophosphate. J Biol Chem 1987;262:14531-7.
28. Becker MA, Taylor W, Smith PR, Ahmed M. Overexpression of the normal phosphoribosylpyrophosphate synthetase I isoform underlies catalytic superactivity of human phosphoribosylpyrophosphate synthetase. J Biol Chem 1996;271:19894-9.
29. Bellwood P The Austronesian dispersal and the origin of languages. Sci Am 1991;265:70-5.
30. Prior IA, Rose BS, Harvey HP, Davidson F. Hyperuricemia, gout and diabetic abnormality in Polynesian people. Lancet 1966;1:333-8.
31. Prior IA. Epidemiology of rheumatic disorders in the Pacific with particular emphasis in hyperuricemia and gout. Semin Arthritis Rheum 1981;11:213-29.
32. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD. The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol 1992;19:1595-9.